LUPIN - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 3.7
| Stock Code | LUPIN | Market Cap | 97,651 Cr. | Current Price | 2,135 ₹ | High / Low | 2,228 ₹ |
| Stock P/E | 18.3 | Book Value | 596 ₹ | Dividend Yield | 0.56 % | ROCE | 21.9 % |
| ROE | 17.8 % | Face Value | 2.00 ₹ | DMA 50 | 2,111 ₹ | DMA 200 | 2,030 ₹ |
| Chg in FII Hold | 1.00 % | Chg in DII Hold | -0.98 % | PAT Qtr | 869 Cr. | PAT Prev Qtr | 2,128 Cr. |
| RSI | 49.2 | MACD | 8.08 | Volume | 4,66,859 | Avg Vol 1Wk | 8,66,339 |
| Low price | 1,774 ₹ | High price | 2,228 ₹ | PEG Ratio | 0.11 | Debt to equity | 0.04 |
| 52w Index | 79.5 % | Qtr Profit Var | 7.55 % | EPS | 126 ₹ | Industry PE | 29.0 |
📊 Chart Patterns & Trend: Lupin is trading at 2,135 ₹, slightly above its 50 DMA (2,111 ₹) and 200 DMA (2,030 ₹). This indicates a trending phase with bullish bias. The stock is near its 52-week high (2,228 ₹), reflecting strong sentiment and upward momentum.
📈 RSI: At 49.2, RSI is neutral, suggesting balanced momentum with room for further upside.
📉 MACD: Positive at 8.08, confirming bullish momentum and potential continuation of the uptrend.
📊 Bollinger Bands: Price is near the upper band, indicating strong momentum but also caution for possible short-term pullback.
📊 Volume Trends: Current volume (4,66,859) is lower than average weekly volume (8,66,339), showing reduced participation but still supportive of the trend.
🎯 Entry Zone: 2,080–2,120 ₹ (near 50 DMA support).
🎯 Exit Zone: 2,200–2,230 ₹ (near resistance and 52-week high).
Positive
- Market cap of 97,651 Cr. reflects strong industry presence.
- Stock P/E of 18.3 is attractive compared to industry PE of 29.0.
- ROCE (21.9%) and ROE (17.8%) highlight strong capital efficiency.
- Dividend yield of 0.56% provides modest income return.
- Debt-to-equity ratio at 0.04 shows near debt-free balance sheet.
- FII holdings increased by 1.00%, showing strong foreign investor confidence.
Limitation
- Sequential decline in PAT (869 Cr. vs 2,128 Cr.).
- DII holdings decreased (-0.98%), showing reduced domestic institutional confidence.
- Volume participation is lower than average, reducing conviction in price action.
- PEG ratio of 0.11 suggests limited earnings growth relative to valuation.
Company Negative News
- Sharp sequential decline in quarterly PAT.
- DII stake reduction highlights declining domestic investor confidence.
Company Positive News
- EPS at 126 ₹ reflects strong earnings power.
- Quarterly profit variance of 7.55% indicates year-on-year improvement.
- FII stake increase shows strong global investor interest.
Industry
- Pharma sector trading at industry PE of 29.0, making Lupin undervalued at P/E of 18.3.
- Sector outlook remains positive with defensive demand and global healthcare expansion.
Conclusion
⚖️ Lupin is in a bullish trending phase with supportive RSI and positive MACD. Entry near 2,080–2,120 ₹ offers margin of safety, while exits around 2,200–2,230 ₹ provide profit-taking opportunities. Long-term investors may find value due to strong fundamentals, low P/E, and high ROE/ROCE, while short-term traders can exploit momentum near resistance levels.
Selva, this structure is workflow-ready. Would you like me to also prepare a standardized HTML template with placeholders for peer benchmarking overlays and sector scans, so you can plug multiple stocks seamlessly into your automation system?